Reducing severe cutaneous adverse and type B adverse drug reactions using pre‐stored human leukocyte antigen genotypes

BACKGROUND: Several type B adverse drug reactions (ADRs), especially severe cutaneous adverse reactions (SCARs), are associated with particular human leukocyte antigen (HLA) genotypes. However, pre‐stored HLA information obtained from other clinical workups has not been used to prevent ADRs. We aime...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Kye Hwa, Kang, Dong Yoon, Kim, Hyun Hwa, Kim, Yi Jun, Kim, Hyo Jung, Kim, Ju Han, Song, Eun Young, Yun, James, Kang, Hye‐Ryun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8760506/
https://www.ncbi.nlm.nih.gov/pubmed/35070271
http://dx.doi.org/10.1002/clt2.12098

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8760506/
https://www.ncbi.nlm.nih.gov/pubmed/35070271
http://dx.doi.org/10.1002/clt2.12098

Ejemplares similares